Related Experiment Video
Updated: Jun 30, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Development of method using language processing techniques for extracting information on drug-health food product
Mari Yoshizaki1,2, Yuki Kuriya2, Masaki Yamamoto2
1Biological Science and Technology, Life and Materials Systems Engineering, Graduate School of Advanced Technology and Science, Tokushima University, Tokushima City, Tokushima Prefecture, Japan.
This study developed a workflow to identify drug-health food product interactions (DHIs) using network analysis and biomedical context. The workflow efficiently extracts both known and potential unknown DHIs, enhancing medication safety.
Area of Science:
- Pharmacology and Bioinformatics
- Drug-Food Interactions
- Computational Biology
Background:
- Health food products (HFPs) can cause adverse drug interactions.
- Information on drug-HFP interactions (DHIs) is crucial for patient safety.
- Existing resources for DHIs are often fragmented.
Purpose of the Study:
- To establish an efficient workflow for extracting Drug-HFP Interactions (DHIs) from open resources.
- To integrate network analysis and biomedical context for DHI prediction.
- To identify both known and potentially unknown DHIs.
Main Methods:
- Collected data on drugs, enzymes, interactions, and known DHIs from public databases and literature.
- Constructed a network of enzymes, HFPs, and drugs, identifying enzymes as interaction hubs.
- Applied BioWordVec to analyze biomedical context and predict potential DHIs.
Main Results:
- Identified 44,965 DHIs (30% known) in the initial network analysis.
- Method 2-1 yielded 7401 DHIs (17% known) by focusing on enzyme-specific HFPs.
- Method 2-2 identified 2819 DHIs (30% known) by selecting HFPs with similar functions to drugs.
Conclusions:
- An integrated workflow combining language processing and network analysis was successfully constructed.
- This workflow enables efficient extraction of a wide range of known and unknown DHIs.
- The developed method enhances the identification of potential drug-health food product interactions.
More Related Videos
Related Concept Videos
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Quantitative Aspects of Drug-Receptor Interaction
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
Agonism and Antagonism: Quantification
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...

